Advanced search    

Search: authors:"Massimo Porta"

24 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Tribute to Professor Guido Pozza, founder and first Editor-in-Chief of Acta Diabetologica

June 2013 to Massimo Porta, the current EiC. Guido Pozza maintained the position of Funding Editor. We will keep with us the memory of a great clinician and researcher, endowed with a deep sense of

Do we need research on reporting on diabetes research?

& Massimo Porta 3 Vita-Salute San Raffaele University , Via Olgettina 60, 20132 Milan , Italy 4 Department of Systems Medicine, University of Rome Tor Vergata , Via Montpellier 1, 00133 Rome , Italy 5

Acta Diabetologica is 50 and well: long live Acta!

Massimo Porta 0 0 M. Porta (&) Department of Medical Sciences, University of Turin , Turin, Italy - Acta Diabetologica has gone through a number of important changes this past year. First, and for ... article does not contain any studies with human or animal subjects performed by the author. Massimo Porta declares he has no conflict of

Inferior vena cava diameters and collapsibility index reveal early volume depletion in a blood donor model

Background Changes of volume status can be readily inferred from variations in diameter of the inferior vena cava (IVC) measured by ultrasound. However the effect of IVC changes following acute blood loss are not fully established. In this study, three different approaches to measuring IVC variables were compared in healthy blood donors, as a model of acute volume depletion, in...

Platelet-derived growth factor regulates the secretion of extracellular vesicles by adipose mesenchymal stem cells and enhances their angiogenic potential

Background Several studies demonstrate the role of adipose mesenchymal stem cells (ASCs) in angiogenesis. The angiogenic mechanism has been ascribed to paracrine factors since these cells secrete a plenty of signal molecules and growth factors. Recently it has been suggested that besides soluble factors, extracellular vesicles (EVs) that include exosomes and microvesicles may...

Association of Autoimmunity to Autonomic Nervous Structures With Nerve Function in Patients With Type 1 Diabetes: A 16-Year Prospective Study

Raviolo Eleonora Coppo Marina Trento Martina Trevisan Franco Cavallo Enrica Favaro Pietro Passera Massimo Porta Giovanni Camussi We prospectively evaluated the association between autoimmunity to autonomic

Clinical characteristics influence screening intervals for diabetic retinopathy

senior diabetes and ophthalmic specialists (respectively, Massimo Porta and Marcello Montanaro), who worked in the programme for the entire 20-year period. Overall quality of retinal photographs was

Prospective, randomized trial on intensive SMBG management added value in non-insulin-treated T2DM patients (PRISMA): a study to determine the effect of a structured SMBG intervention

Self-monitoring of blood glucose (SMBG) is a core component of diabetes management. However, the International Diabetes Federation recommends that SMBG be performed in a structured manner and that the data are accurately interpreted and used to take appropriate therapeutic actions. We designed a study to evaluate the impact of structured SMBG on glycemic control in non-insulin...

No Sign of Proliferative Retinopathy in 15 Patients With Permanent Neonatal Diabetes With a Median Diabetes Duration of 24 Years

Massa 2 Maurizio Sudano 11 Francesco Cadario 12 Massimo Porta 10 Fabrizio Barbetti 2 8 the Early Onset Diabetes Study Group of the Italian Society of Pediatric Endocrinology Diabetology (ISPED) 0

Infant and Toddler Type 1 Diabetes: Complications after 20 years’ duration

OBJECTIVE To compare the effect of the prepubertal duration of diabetes on the occurrence of complications in two groups of patients after the same number of years of the disease.

Rethink Organization to iMprove Education and Outcomes (ROMEO): A multicenter randomized trial of lifestyle intervention by group care to manage type 2 diabetes

OBJECTIVE A trial was performed to establish whether our group care model for lifestyle intervention in type 2 diabetes can be exported to other clinics. RESEARCH DESIGN AND METHODS This study was a 4-year, two-armed, multicenter controlled trial in 13 hospital-based diabetes clinics in Italy (current controlled trials no. ISRCTN19509463). A total of 815 non–insulin-treated...

Relationship Between Risk Factors and Mortality in Type 1 Diabetic Patients in Europe: The EURODIAB Prospective Complications Study (PCS)

SABITA S. SOEDAMAH-MUTHU PHD NISH CHATURVEDI DANIEL R. WITTE PHD LYNDA K. STEVENS MSC MASSIMO PORTA JOHN H. FULLER FOR THE EURODIAB PROSPECTIVE COMPLICATIONS STUDY GROUP E p i d e m i o l o g y / H

A 5-Year Randomized Controlled Study of Learning, Problem Solving Ability, and Quality of Life Modifications in People With Type 2 Diabetes Managed by Group Care

OBJECTIVE—To study time course changes in knowledge, problem solving ability, and quality of life in patients with type 2 diabetes managed by group compared with individual care and education. RESEARCH DESIGN AND METHODS—We conducted a 5-year randomized controlled clinical trial of continuing systemic education delivered by group versus individual diabetes care in a hospital...